Skip to main content
Have a personal or library account? Click to login
Humoral response after breakthrough SARS-CoV-2 infection in type 2 diabetes mellitus patients Cover

Humoral response after breakthrough SARS-CoV-2 infection in type 2 diabetes mellitus patients

Current Issues in Pharmacy and Medical Sciences
Volume 36 (2023): Issue 4 (December 2023)
By: ,  ,  ,  ,  ,   and    
Open Access
|Dec 2023
Authors

Authors

Aleksander Michalski

1Clinical Military Hospital with Outpatient Clinic in Lublin, Poland

Magdalena Goralczyk

Department of Virology with Viral Diagnostics Laboratory, Medical University of Lublin, Poland

Michal Brzozowski

1Clinical Military Hospital with Outpatient Clinic in Lublin, Poland

Jakub Dworzanski

Masovian Specialist Hospital, Radom, Poland

Bartlomiej Drop

Department of Computer Science and Medical Statistics with the e-Health Laboratory, Lublin, Poland

Ewa Stepien

ewa.stepien@umlub.pl

Department of Virology with Viral Diagnostics Laboratory, Medical University of Lublin, Poland

Malgorzata Polz-Dacewicz

Department of Virology with Viral Diagnostics Laboratory, Medical University of Lublin, Poland
DOI: https://doi.org/10.2478/cipms-2023-0038 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 221 - 226
Submitted on: Jul 6, 2023
Accepted on: Nov 15, 2023
Published online: Dec 25, 2023
Published in print: Dec 1, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Keywords:
SARS-CoV-2 antibody,
diabetes,
NCP,
RBD,
S2,
vaccination
Related subjects:
Medicine,
Clinical medicine,
Pharmacology, toxicology

© 2023 Aleksander Michalski, Magdalena Goralczyk, Michal Brzozowski, Jakub Dworzanski, Bartlomiej Drop, Ewa Stepien, Malgorzata Polz-Dacewicz, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 36 (2023): Issue 4 (December 2023)
Previous article
Next article